4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-018202
Options or other derivatives
- Chief Operating Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Prince Joshua S. Chief Operating Officer | 2025-06-23 | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/form4-06252025_050605.xml…